Ormat Technologies Inc. Securities Litigation (2018)

According to the Complaint, Ormat Technologies Inc. ("Ormat") engages in the geothermal and recovered energy power business worldwide.

See Case Details »

Desarrolladora Homex, S.A.B. de C.V. (a/k/a Homex Development Corp.) : American Depositary Shares Securities Litigation

According to the law firm press release, the lawsuit alleges defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) between 2010 and 2013, Homex overstated its revenue by 355% or roughly $3.3 billion by reporting fictitious sales of more than 100,000 homes; (2) between 2010 and 2013, Homex overstated the number of units it sold by over 100,000 units or 317% of actual units sold; (3) Homex and certain of its Headquarters Financial Reporting Personnel knowingly and intentionally engaged in a scheme to materially overstate Homex's revenues, homes sold, and other related financial items; and (4) as a result, defendants' statements about Homex's business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

See Case Details »

APYX Medical Corporation f/k/a/ Bovie Medical Corporation Securities Litigation

According to the Complaint, APYX Medical Corporation is a medical technology company that purportedly develops J-Plasma, a plasma-based surgical product for cutting, coagulation and ablation of soft tissue. The Company markets and sells J-Plasma under the brand name Renuvion Cosmetic Technology. The Company claims that it has developed J-Plasma/Renuvion for use in dermal resurfacing procedures. Apyx was formerly known as Bovie Medical Corporation, and its stock traded on the New York Stock Exchange ("NYSE") under the symbol "BVX" until January 1, 2019.

See Case Details »

American Renal Associates Holdings, Inc. Securities Litigation (2019)

According to the Complaint, American Renal purports to operate as a dialysis services provider in the United States.

See Case Details »

First Choice Healthcare Solutions, Inc. Securities Litigation

Plaintiff's law firm issued a press release on March 29, 2019 announcing the filing of the lawsuit. The Complaint alleges that during the Class Period, Defendants were engaged in an undisclosed pump and dump scheme that manipulated and artificially inflated the price of First Choice common stock, and failed to disclose their involvement, rendering certain of their public statements materially misleading.

See Case Details »